Search results for "Dizziness"
Drug adverse events affect patients' choices more than benefits
Central line infections in ICUs fell 58% between 2001 and 2009
https://immattersacp.org/weekly/archives/2011/03/08/5.htm
8 Mar 2011
Warnings issued for antiepileptics, bowel prep, efalizumab
A summary of approvals, recalls, warnings and alerts.
https://immattersacp.org/archives/2009/02/fda.htm
1 Feb 2009
MKSAP Quiz: fatigue, weight gain and constipation
Higher doses of prescribed opioids associated with increased overdose risk
https://immattersacp.org/weekly/archives/2010/01/26/3.htm
26 Jan 2010
Warnings on power cords, asthma drugs, diabetes supplies
A summary of approvals, recalls, warnings and alerts digested by ACP Internist from the Food and Drug Administration's alerts.
https://immattersacp.org/archives/2009/11/fda.htm
1 Nov 2009
MKSAP Quiz: evaluation for health insurance
A 21-year-old man is evaluated during a medical examination for health insurance. The patient is a weight lifter. He has no medical problems and takes no medications or illicit drugs. Following a physical exam, electrocardiogram, and echocardiogram, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2014/08/05/3.htm
5 Aug 2014
Internal Medicine 2011 offers several new pre-courses
New offerings at ACP's annual meeting will include learning how to use portable ultrasound technology, the anatomy behind and diagnoses of common orthopedic complains, and an expanded neurological course including headache, dizziness and stroke.
https://immattersacp.org/archives/2011/03/IM.htm
1 Mar 2011
Searching for signs of eating disorders
Internists are often the first clinicians to see signs of an eating disorder, with the rapid or extreme changes in weight apparent both in person and from the history recorded in a patient's chart. But primary care clinicians may sometimes be afraid to ask about it because they are unsure how to handle what they might learn.
https://immattersacp.org/archives/2013/02/eating.htm
1 Feb 2013
New warnings added on multiple diabetes drugs
This update also covers a risk evaluation and mitigation strategy for liraglutide and approval of a new PCSK9 inhibitor.
https://immattersacp.org/archives/2015/11/fda.htm
1 Nov 2015
Managing depression is worth the effort
Depression's impact on health is often profound and far-reaching, potentially equaling that of coronary artery disease. To provide clinicians with guidance on treatment of depression, ACP has released a new clinical practice guideline that underscores the severe burden of depression and outlines viable treatment options for patients.
https://immattersacp.org/archives/2016/05/depression.htm
1 May 2016
Medical marijuana may help relieve some multiple sclerosis symptoms but has several safety concerns
Certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but they do not appear to be helpful in treating drug-induced movements in Parkinson's disease, a review by the American Academy of Neurology found.
https://immattersacp.org/weekly/archives/2014/04/29/1.htm
29 Apr 2014